<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(7)</volume><submitter>Xu X</submitter><pubmed_abstract>Chimeric antigen receptor T cells are T cells genetically engineered with CAR constructs which mainly contain scFV and TCR zeta chain. With promising development in blood cancers, CAR T trials are also applied in solid cancers. However, the treatment effect in solid cancers is lower than expected. This review summarizes difference of CAR T applications in solid and blood cancers. Future challenges of CAR T cell treatment in solid cancer are also discussed using ovarian cancer as an example.</pubmed_abstract><journal>Human vaccines &amp; immunotherapeutics</journal><pagination>1548-1555</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5512759</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a model.</pubmed_title><pmcid>PMC5512759</pmcid><pubmed_authors>Qiu J</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a model.</name><description>Chimeric antigen receptor T cells are T cells genetically engineered with CAR constructs which mainly contain scFV and TCR zeta chain. With promising development in blood cancers, CAR T trials are also applied in solid cancers. However, the treatment effect in solid cancers is lower than expected. This review summarizes difference of CAR T applications in solid and blood cancers. Future challenges of CAR T cell treatment in solid cancer are also discussed using ovarian cancer as an example.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jul</publication><modification>2025-04-19T18:42:55.275Z</modification><creation>2019-03-26T23:06:43Z</creation></dates><accession>S-EPMC5512759</accession><cross_references><pubmed>28272967</pubmed><doi>10.1080/21645515.2017.1291473</doi></cross_references></HashMap>